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Abstract 
The antibiotic batumin, produced by Pseudomonas batumici, has been shown to be highly active 
against 123 type and reference strains and clinical isolates of 30 Staphylococcus species (including 
MRSA and small colony variants—(SSCVs) of S. aureus, S. epidermidis and S. haemolyticus). Batu-
min activity against these bacteria did not depend on the species, origin or resistance to other an-
tibiotics and its MIC was 0.0625 - 0.5 µg/ml. Batumin influence on biofilm formation was studied 
in clinical isolates of S. aureus, S. epidermidis and S. intermedius. Addition of batumin at a concen-
tration of half of the MIC in the broth, i.e. 0.125 µg/ml, decreased the biofilm of 16 out of 20 S. au-
reus strains to varying degrees. Batumin was more effective against Staphylococcus strains with 
strong biofilm formation. Using atomic-force microscopy, it could be shown that batumin reduced 
the number of S. aureus ATCC 25923 adherent cells more than fourfold. The adherent cells of sta-
phylococci were visualized as monolayers of separate islets. A detailed study of the surface of bac-
terial cells treated with batumin allowed to establish significant reduction of their roughness val-
ues. Observed values were typical for planktonic S. aureus cells. The obtained data explain one of 
the mechanisms of the antimicrobial activity of batumin, which is based оn preventing the forma-
tion of S. aureus biofilm. As such, batumin could be considered as an agent offering opportunities 
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for the treatment of staphylococcal biofilm-associated infections. 
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1. Introduction 
Batumin, a polyketide antibiotic, produced by Pseudomonas batumici, has high and selective activity against 
staphylococci [1] [2]. This predetermined its use not only for treatment of infections and nasal carriage of sta-
phylococci but also for diagnosis of staphylocococcal infection, using the “Diastaph” preparation, which con-
sists of batumin-impregnated disks [3]. The high susceptibility of staphylococci to batumin distinguishes them 
from representatives of other taxons, as was demonstrated using “Diastaph” in several thousands of clinical iso-
lates of bacteria [4].  
Bacteria growing as biofilm are highly resistant to antibiotics [5]. However, our previous studies have shown 
that addition of half the concentration of the batumin MIC (0.125 μg/ml) to the media considerably reduced bio-
film formation in 80% of nasal staphylococcal strains, which had initially high levels of biofilm formation [6].  
The objective of this work was to broaden our knowledge about batumin activity against Staphylococcus spe-
cies, against atypical forms of this pathogen, i.e. small staphylococcal colony variants (SSCVs), and to obtain 
more detailed insights into the influence of batumin on biofilm formation by using atomic-force microscopy.  
2. Materials and Methods  
Batumin, obtained by fermentation of Pseudomonas batumici and purified by silica gel preparative chromato-
graphy to 85% of purity, was used. 
Batumin is commercially available from Santa Cruz Biotechnology (Santa Cruz, CA) or Enzo Life Sciences 
(Antwerp, Belgium). 
Type and collection strains of 30 different species belonging to the genus Staphylococcus (Table 1) and 50 
methicillin resistant S. aureus (MRSA) strains isolated in the Institute of Traumatology and Orthopedics, Medi-
cal Science Academy of Ukraine, from patients with osteomyelitis, were included. 20 Staphylococcus aureus 
strains, 19 Staphylococcus epidermidis and 4 Staphylococcus intermedius strains, isolated from skin microbial 
biocenosis and nasal mucous membrane (microbial collection of the Institute of cellular and intracellular symbi-
osis Ural Branch of Russian Academy of Sciences, Orenburg, Russia) were also studied for their susceptibility 
to batumin and for its antibiotic effect upon biofilm formation. Thus, in total 123 strains of staphylococci were 
included. 
Identification of MRSA was carried out according to methods described in [7]. Susceptibility of staphylococ-
cal clinical strains to a wide spectrum of antibiotics was tested by the Kirby-Bauer method. NCCLS criteria [8] 
were used to interpret the susceptibility to antibiotics. 
Thirty strains of SSCVs were isolated as subpopulations on Columbia agar with 5% sheep blood, as pinpoint 
colonies (0.1 - 0.3 mm) after 48 hours of aerobic incubation at 37˚C, among the more numerous colonies (2 - 3 
mm) with normal Staphylococcus morphology, considered as the parental isolates of the SSCVs. Identification 
of the staphylococci was carried out according to standard methods [9]. 
The atypical forms of staphylococci were previously identified by standard methods and using tDNA-PCR 
analysis and were assigned to three species: S. aureus, S. epidermidis and S. haemolyticus. Their detailed de-
scription was presented previously [10].  
The minimal inhibitory concentration (MIC) of batumin was studied according to CLSI Standards (2005) in 
Mueller-Hinton agar or broth [11]. The microbial load of SSCVs was 0.5 × 108 cfu/ml and the Petri dishes were 
incubated at 37°С for 48 hours.  
Half the MIC of batumin was used to study its effect upon biofilm formation in staphylococci. Biofilm forma-
tion was studied by a photometric method determining the bacterial capacity to adhere onto the 96-hole polys-
tyrole plane-table surface with subsequent crystal violet colouring [12]. Optical density measurement was done 
using a photometer ELx808 (BioTek, USA) at a wavelength of 630 nm. Degree of biofilm formation was ex-
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pressed in conditional units (un.) which was the optical density of studied strain (experiment) in relation to the 
nutrient broth density (the control). 
For the study of batumin effect on biofilm formation we used S. aureus B-904 (UCM) as test-culture. For bio-
film production, glass coverslips were immersed into Luria-Bertani broth with 0.125 μg/ml of batumin and in-
cubated for 48 h at 37˚C.  
Visualization of the biofilms was done by atomic force microscopy using the SMM-2000 microscope (Proton- 
MIET Closed JOINT Stock Company, Russia), in contact mode in air environment [13] [18]. 
3. Results and Discussion 
The susceptibility to batumin of Staphylococcus species reference strains of some collection strains and of me-
thicillin-resistant S. aureus strains are presented in (Table 1). It is of interest to note the high uniformity of the 
susceptibility to batumin for the different Staphylococcus species. Batumin inhibited most of the studied strains 
and species, including MRSA, at concentrations between 0.25 and 0.5 μg/ml, and rarely 1.0 μg/ml was needed. 
 
Table 1. Susceptibility to batumin of species belonging to different 16S RNA complexes of the genus Staphylococcus. 
RNA-complex Species (strain number) MIC µg/ml 
S. aureus 
S. aureus B-918 (ATCC 6538) 
S. aureus B-4001 (ATCC 6538P) 
S. aureus B-904 (ATCC 25923) 
S. aureus B-909 (GISK 906) 
MRSA (50 strains) 
0.25 
0.25 
0.25 
0.25 
0.25 - 0.5 
S. carnosus 
S. carnosus B-4005T (DSM 20501T) 
S. piscifermentans B-4028T (ATCC 51136T) 
S. simulans B-4033T (ATCC 27848T) 
0.25 
0.25 
0.25 
S. epidermidis 
S. capitis B-4002Т (АТСС 27840T) 
S. caprae B-4007T (ATCC 35538T) 
S. epidermidis B-4023T (ATCC 14990Т) 
S. epidermidis B-919 (ATCC 12,228) 
0.125 
0.125 
0.0625 
 
S. haemolyticus 
S. devriesei B-4022T (CNS 159T) 
S. haemolyticus B-4018T (АТСС 29970T) 
S. hominis B-4019T (DSM 20328T) 
0.125 
0.25 
0.25 
S. hyicus-S. intermedius 
S. chromogenes B-4003T (ATCC 43764T) 
S. felis B-4016T (ATCC 49168T) 
S. delphini B-4008T (ATCC 49171T) 
S. hyicus B-4020T (ATCC 11249T) 
S. intermedius B-4009T (ATCC 29663T) 
S. schleiferi B-4032T (ATCC 49545T) 
S. pseudointermedius B-4029T (LMG 22219T) 
0.25 
0.25 
0.25 
0.25 
0.5 
0.5 
0.25 
S. lugdunensis S. lugdunensis B-4025T (ATCC 43809T) 0.5 
S. warneri S. warneri B-4013
T (ATCC 27836T) 
S. pasteurii B-4026T (ATCC 51129T) 
0.25 
0.25 
S. sciuri 
S. sciuri B-4012T (ATCC 290762T) 
S. pulvereri B-4031T (ATCC 51698T) 
S. lentus B-4024T (CCM 2598T) 
S. lentus B-4010 (ATCC 29,070) 
0.5 
1.0 
0.5 
0.5 
S. saprophyticus 
S. equorum B-4015T (ATCC 43959T) 
S. gallinarum B-4017T (ATCC 35539T) 
S. kloosii B-4021T (ATCC 43959T) 
S. saprophyticus B-4011T (ATCC 15305T) 
S. saprophyticus B-4034 (CLO 059) 
S. cohnii B-4004T (ATCC 29974T) 
S. xylosus B-4014T (ATCC 29971T) 
0.5 
0.5 
1.0 
0.25 
0.5 
0.25 
0.25 
Macrococcus caseolyticus M. caseolyticus B-4006T (ATCC 13548T) 0.125 
The strain numbers of the Ukrainian Collection of Microorganisms (UCM) are presented. Numbers from АТСС or from other collections between 
brackets. 
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Our data show that the most susceptible species to batumin were species of the S. epidermidis complex (МIC 
0.0625 - 0.125 μg/ml). Strains of this complex demonstrated the highest batumin susceptibility also during pre-
vious clinical trials (unpublished data).  
Figure 1 shows the antibiotic-resistance profile of the studied MRSA strains, indicating that these strains are 
resistant to all commonly used antibiotics. At the same time, all 50 strains—regardless their origin and their 
susceptibility to different antibiotics—were inhibited by 0.5 μg/ml of batumin. 
Batumin is also effective against macrococci which were set separately from the genus Staphylococcus and 
included in the new genus Macrococcus. On the other hand, Gemella morbillorum and G. haemolysans, isolated 
from osteomyelitis patients, did not show growth inhibition zones around batumin disks [14], despite their rela-
tionship to staphylococci. Batumin was also not effective against bacilli, Listeria, planococci and other bacteria 
which belong to the order of the Bacillales, comprising the family of the Staphylococcaceaе [2] [4].  
Data presented here, as well as studies of the past years, demonstrate high activity of batumin against meta-
bolically normal members of the genus Staphylococcus [2] [3], as well as against atypical forms of staphylococ-
ci, the so-called small colony-variants (SSCVs). SSCVs are formed as a result of mutations and characterized by 
a complex pleiotropic phenotype which can be largely explained by defective electron transport [15] [16]. 
All 30 SSCVs included in this study were isolated on solid growth media as a subpopulation among the larger 
number of colonies with normal for staphylococci morphology. They were characterized by altered colony 
morphology, delayed growth and lack of pigmentation. Moreover, many of them lacked lecithinase, phosphatase, 
coagulase and haemolytic activity and the metabolism of carbohydrates such as sucrose, lactose and fructose 
was altered, which is consistent with the literature and with our previous results [10] [17].  
Coming from our previous data on batumin antimicrobial action against SSCVs we first estimated this effect 
studying the growth inhibiting concentrations.  
Most of the SSCVs were inhibited by a concentration of 0.25 μg batumin/ml. Strain S. aureus 71 was most 
resistant, with an MIC of 0.5 μg/ml. 
So the data presented in this work and first obtained using strains of practically all known staphylococci spe-
cies, multiresistant clinical isolates and atypical forms of this pathogen give evidence that batumin is highly ac-
tive selective inhibitor of representatives of the genus Staphylococcus. 
Susceptibility of nasal and skin clinical isolates of staphylococci to batumin was the same as of type and col-
lection strains of different species of the genus Staphylococcus studied before [6]. At the same time, the antibi-
otic effect against biofilm formation was different in different strains and species. Their biofilm formation val-
ues varied from 2.6 - 3.1 CU for S. aureus to 1.8 - 2.3 for S. epidermidis and 1.7 - 1.9 for S. intermedius strains 
(Table 2). Presence of half of batumin MIC in the broth reduced the biofilm formation in 85% of studied  
 
 
Figure 1. The antibiotic resistance profiles of 50 methicillin-resistant Staphylococcus aureus strains. 
Legend: x-axis: studied antibiotics; y-axis: % of MRSA strains, resistant to these antibiotics. 
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Table 2. Batumin effect against biofilm formation by staphylococci. 
Strains Source of  isolation 
Optical density (OD630)  
without batumin 
CU* without  
batumin 
Optical density (OD630)  
batumin (0.125 μg/ml) 
CU* batumin  
(0.125 μg/ml) 
1  Reference 0.131 2.6 0.095 1.9 
2 S. aureus 3 Nose 0.157 3.1 0.077 1.5 
3 S. aureus 17 Nose 0.134 2.7 0.094 1.9 
4 S. aureus 24 Nose 0.142 2.8 0.104 2.1 
5 S. aureus 28a Nose 0.131 2.6 0.091 1.8 
6 S. aureus 29 Nose 0.130 2.6 0.083 1.7 
7 S. aureus 35 Skin 0.131 2.6 0.096 1.9 
8 S. aureus 39 Colon 0.136 2.7 0.074 1.5 
9 S. aureus 59d Skin 0.131 2.6 0.132 2.6 
10 S. aureus 68 Skin 0.132 2.6 0.097 1.9 
11 S. aureus 75 Nose 0.156 3.1 0.157 3.1 
12 S. aureus 89-a Colon 0.147 2.9 0.081 1.6 
13 S. aureus 104-a Colon 0.142 2.8 0.105 2.1 
14 S. aureus 120 Nose 0.156 3.1 0.155 3.1 
15 S. aureus 121 Nose 0.131 2.6 0.093 1.9 
16 S. aureus 132 Nose 0.131 2.6 0.095 1.9 
17 S. aureus 146-a Nose 0.130 2.6 0.081 1.6 
18 S. aureus 144 Skin 0.135 2.7 0.090 1.8 
19 S. aureus 159 Skin 0.140 2.8 0.084 1.7 
20 S. aureus 165 Skin 0.130 2.6 0.133 2.6 
21 S. epidermidis 11 Skin 0.105 2.1 0.085 1.7 
22 S. epidermidis 47 Skin 0.115 2.3 0.095 1.9 
23 S. epidermidis 57k Skin 0.105 2.1 0.105 2.1 
24 S. epidermidis 61 Skin 0.105 2.1 0.105 2.1 
25 S. epidermidis 64 Nose 0.115 2.3 0.115 2.3 
26 S. epidermidis 73 Nose 0.095 1.9 0.08 1.6 
27 S. epidermidis 99-b Skin 0.097 1.9 0.095 1.9 
28 S. epidermidis 124 Nose 0.104 2.1 0.107 2.1 
29 S. epidermidis 137 Skin 0.105 2.1 0.093 1.9 
30 S. epidermidis 140 Skin 0.092 1.8 0.080 1.6 
31 S. epidermidis 143 Nose 0.094 1.9 0.097 1.9 
32 S. epidermidis147 Skin 0.111 2.2 0.095 1.9 
33 S. epidermidis 154 Nose 0.097 1.9 0.096 1.9 
34 S. epidermidis 155 c Colon 0.091 1.8 0.09 1.8 
35 S. epidermidis 172 Nose 0.114 2.3 0.113 2.3 
36 S. epidermidis 183 Nose 0.115 2.3 0.091 1.8 
37 S. epidermidis 184 Nose 0.095 1.9 0.084 1.7 
38 S. epidermidis 215 Colon 0.113 2.3 0.115 2.3 
39 S. epidermidis 187 Nose 0.11 2.2 0.11 2.2 
40 S. intermedius 193 Nose 0.083 1.7 0.075 1.5 
41 S. intermedius 195 Nose 0.095 1.9 0.074 1.5 
42 S. intermedius 107 Skin 0.09 1.8 0.09 1.8 
43 S. intermedius 111 Skin 0.086 1.7 0.084 1.7 
*The ratio of the optical density of the samples in the experiment and control. Expressed as conventional unit (CU) = OD630 in experimental sam-
ples/OD630 in control samples. Optic density of control samples is 0.05, which is the nutrient broth density. 
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S. aureus strains. It should be noted that batumin is more effective against Staphylococcus strains with strong 
biofilm formation (CU values between 2.6 and 3.1). 
Analysis of experimental data on batumin effect on the stages of biofilm formation in S. aureus demonstrated 
that the effectiveness of batumin depended on the stage of biofilm formation (Table 3). Simultaneous batumin 
addition with S. aureus into culture medium promoted reduction of biofilm formation values in all studied sta-
phylococci strains, at that already formed film was more resistant to studied preparation. 
More detailed study of batumin action upon S. aureus biofilm formation was carried out using atomic force 
microscopy. The object of this study was the reference strain S. aureus UCM B-904. This strain formed biofilm 
on the surface of the glass, as can be seen from Figure 2(a). Surface biofilm was formed by exopolymeric ma-
trix with cells of round shape immersed in it (Figure 2(b)).  
For strain S. aureus B-904, the effect of batumin with regard to biofilm formation disturbance corresponded 
to a more than fourfold decrease of the number of adherent cells. Moreover, in the presence of batumin, the cells 
of staphylococci were observed in the form of monolayer of separate islets (Figure 2(c)). Particles of exopoly-
meric matrix were determined with average values of thickness of 63 - 62 nm, located between the cells and on 
their surface (Figure 2(d)). In this case the transverse dimension of cells was 0.64 ± 0.08 mm, not significantly 
different from control values. A detailed study of the surface of bacterial cells treated with batumin allows to 
establish significant reduction of their roughness values (Table 4). Observed values were typical for planktonic 
S. aureus cells [19]. 
Atomic force microscopy revealed qualitative and quantitative changes in the exopolymeric matrix due to ba-
tumin treatment, as well as a significant reduction in the number of cells adhered to the coverslip, preventing 
formation of S. aureus biofilm. 
 It is known that some biofilms are covered by a surface film composed of lipid components similar to those 
in bacterial membranes which are a barrier for the penetration of antibiotics [20]. We have previously shown 
that batumin has significant effects on lipid metabolism of S. aureus [21]. Based on the similarity of a biofilm 
matrix lipid on the one hand and membrane of bacterial cell on the other hand, it can be assumed that batumin 
penetrates well into staphylococcal biofilm, explaining the significant changes of exopolymeric matrix that can 
be observed.  
4. Conclusions 
The data presented in this work show that batumin is a highly active antimicrobial agent, inhibiting all species of 
staphylococci and macrococci, regardless their origin or antibiotic susceptibility. The MIC-values for batumin  
 
Table 3. Influence of batumin (0.125 µg/ml) on the steps of biofilm formation by Staphylococcus aureus. 
Strains 
Before batumin After batumin (simultaneously with inoculation) 
After batumin  
(90 min) 
After batumin  
(24 hours) 
After batumin  
(48 hours) 
Optical  
density CU
* Optical density (OD630) CU* 
Optical density 
(OD630) 
CU* Optical density (OD630) 
CU* Optical density (OD630) 
1 S. aureus 25923 ATCC 0.132 2.6 0.097 1.9 0.081 1.6 0.135 2.7 0.164 
2 S. aureus 3 0.155 3.1 0.074 1.5 0.153 3.0 0.155 3.1 0.153 
3 S. aureus 17 0.137 2.7 0.095 1.9 0.099 2.0 0.105 3.1 0.135 
4 S. aureus 24 0.140 2.8 0.102 2.0 0.140 2.8 0.169 3.4 0.142 
5 S. aureus 28a 0.133 2.7 0.090 1.8 0.156 3.1 0.161 3.2 0.161 
6 S. aureus 35 0.130 2.6 0.094 1.9 0.103 2.1 0.130 2.6 0.130 
7 S. aureus 39 0.138 2.8 0.071 1.4 0.085 1.7 0.084 1.7 0.077 
8 S. aureus 68 0.132 2.6 0.095 1.9 0.097 1.9 0.097 1.9 0.093 
9 S. aureus 89-a 0.148 3.0 0.079 1.6 0.097 1.9 0.089 1.8 0.147 
10 S. aureus 121 0.133 2.7 0.093 1.9 0.101 2.0 0.101 2.0 0.155 
11 S. aureus 144 0.131 2.6 0.087 1.7 0.094 1.9 0.088 1.8 0.085 
12 S. aureus 159 0.142 2.8 0.085 1.7 0.141 2.8 0.183 3.7 0.140 
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Figure 2. Аtomic force microscopy-topography images of Staphylococcus aureus B-904. ((а) (b)) S. aureus B-904 without 
batumin; ((c) (d)) S. aureus B-904 grown in the presence of 0.125 μg/ml of batumin. Arrows: 1: particles of exopolymeric 
matrix; 2 bacterial cells; Scale—2 μm ((a) (b)); 1 μm ((c) (d)). 
 
Table 4. Morphological characteristics of cells and adherence to glass of S. aureus B-904 in the presence of 0.125 µg/ml ba-
tumin. 
Conditions of the experiment Adherent cells, % Length (µm) Width (µm ) Height (µm) Roughness values (nm) 
Control  
(without batumin) 100 ± 11 0.69 ± 0.05 0.64 ± 0.08 N/A
** 19.4 ± 5.50 
Experiment (half MIC of batumin,  
i.e. 0.125 µg/ml) 24 ± 4
* 0.73 ± 0.12 0.64 ± 0.07 0.68 ± 0.08 9.59 ± 1.43* 
*p < 0.05 (Mann-Whitney U-test). **To determine bacterial cell length and width, cells that were at least immersed into exopolymeric matrix were se-
lected. However, height determination of the cells in this case would have been incorrect and therefore was not implemented. 
 
range between 0.25 and 0.5 µg/ml, rarely reaching 1.0 μg/ml. It should be noted that these results were obtained 
with 85% pure batumin, whereas, according to [22], the MIC of 95% pure batumin against S. aureus was much 
higher, i.e. 0.05 μg/ml.  
Probably batumin differs in its mechanism of antimicrobial action from all antibiotic substances used at 
present in clinical practice, and the nature of its selectivity is connected with some peculiarity of staphylococcal 
metabolism which sets them apart from other genetically related bacteria. Taking into account, the polyketide 
nature of batumin and our earlier data about batumin activity upon Staphylococcus lipids [21], we may suppose 
that these distinctions are determined by specific characteristics of the staphylococcal fatty acids metabolism. 
The obtained data on atomic force microscopy explain one of the mechanisms of the antimicrobial action of 
batumin, based оn preventing formation of S. aureus biofilm that allows considering it as a promising agent in 
treatment of staphylococcal biofilm-associated infections. 
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